‘Extremely experienced’ in the tech and life sciences sectors, the Taylor Wessing LLP practice regularly advises both domestic and international clients on the gamut of fundraising, capital raising, and investment round matters. Displaying a strong track record in seed investment and funding rounds, the department leverages its tech expertise to cover a range of issues relating to data privacy, GDPR compliance, and IP tracking. The ’high-calibre’ practice head Howard Palmer stands out for his track record in investment advice, primarily in the cleantech and fintech spheres. The ‘extremely experienced’ Josef Fuss regularly assists investors, entrepreneurs, and management teams. Other names to note include Alexandra Richardson, who supports companies from the start-up stage through to exit; Cambridge-office head Ross McNaughton, an expert in the biotech and medical device spaces, and Ian Moore, who concentrates on e-commerce and retail tech businesses. Angus Miln left the firm to join Cooley (UK) LLP in September 2024.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • 'An extremely experienced and hardworking team! lots of knowledge and numerous partners globally supporting these activities.’

  • ‘Josef Fuss is a great partner, accountable, extremely experienced and always available to support. Deepti Patankar is very experienced hard-working associate always keen to assist.’

  • 'The perfect mix of legal and business knowledge/experience as well as timely execution - we are always ahead of and driving our counterparties in any deal.’

  • 'Howard Palmer is high-calibre. Bhavna Pattanaik is also a superstar.’

Key clients

  • Apollo Therapeutics
  • Dawn Capital
  • HiBob
  • World Fund
  • Geopura
  • Vortexa
  • Portage Ventures
  • Lottie
  • Google Ventures
  • Signature Technologies
  • Infinitopes
  • Camena Bioscience
  • Base Immune
  • Multiomic
  • Tagomics
  • Phagenesis

Work highlights

  • Advised on a $260m Series C fundraising for Apollo Therapeutics, a Cambridge-headquartered biopharmaceutical company progressing transformative treatments based on breakthrough discoveries.
  • Advised Dawn Capital on its investment as part of a $129m Series E fundraising for Quantexa at a valuation of $1.8bn.
  • Advised HiBob, an Israeli HR management platform, on their $150m Series D funding round.

Lawyers

Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.

Practice head

The lawyer(s) leading their teams.

Howard Palmer

Other key lawyers

Josef Fuss, Alexandra Richardson, Ross McNaughton, Ian Moore, Elinor Picton, Richard Price, Oli Denne